Page 9 - Pharma Services News Today

Received authorization from the U.S. FDA and approval from the European Commission for the Companys updated COVID-19 vaccine, and launched the only...

NeoGenomics (NASDAQ:NEO – Get Free Report) updated its FY 2023 earnings guidance on Monday. The company provided earnings per share guidance of -$0.18–$0.15 for the period, compared to the consensus earnings per share estimate of -$0.28. The company issued revenue guidance of $585.00 million-$592.00 million, compared to the consensus revenue estimate of $573.19 million. Analyst […]

Think Research Supporting the Province of Nova Scotias YourHealthNS ...

Novo Nordisk is spending billions of dollars to boost output and ease shortages of its hugely popular, highly effective weight-loss medicine Wegovy. The Danish drugmaker, which reports...

Novo depends upon a number of companies to help produce Wegovy, but it has released scant details on its supply chain for the weight-loss medicine and its diabetes drug Ozempic containing the same active ingredient. Here are the details of the manufacturing supply chain, based on public statements by Novo and Reuters' reporting: ACTIVE PHARMACEUTICAL INGREDIENT (API) The active pharmaceutical ingredient (API) contained in Wegovy is called semaglutide. Novo says that it produces all of the A...

The Lagos State Internal Revenue Service (LIRS) has shut down 34 companies over failure to remit personal income tax of their employees and non-remittance

NeoGenomics (NASDAQ:NEO – Free Report) had its price objective cut by Morgan Stanley from $18.00 to $16.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Several other research analysts have also recently issued reports on the company. Piper Sandler lowered […]

Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmaceutical services industry this week, as it fuels a boom for firms that fill and assemble the self-injection pens. A surge in sales of Novo Nordisk's drug Wegovy, which launched in the United States in mid-2021, has propelled the Danish drugmaker to become Europe's most valuable company. U.S. rival Eli Lilly has become the world's most valuable healthcare firm this year as ...

/PRNewswire/ -- By the end of the year 2022, the net worth of the pharmaceutical contract packaging market was reported to have reached US$ 5.6 billion. As per...

Crosstree, the global leader in health sciences M&A, is thrilled to announce the appointment of Sandra G. Callahan to the position of chief marketing and growth officer, the first in the firm's history, and the addition of three new directors. These hires mark a turning point in the firm's trajectory and further solidify Crosstree's position as the largest strategic advisory team exclusively dedicated to Health Sciences.